From innovation to commercialization.From one market to the next.From strategy to execution.

Questions that matter: the decisions we help clients navigate.

From prioritizing markets to shaping the operating model and preparing for commercialization, we help leadership teams navigate pivotal business decisions.

  1. Which European markets or U.S. opportunities should we prioritize?
  2. Should we commercialize directly or partner in Europe or the U.S.?
  3. What does it take for a U.S. biopharma company to launch successfully in Europe—and vice versa?
  4. When should we build our commercial organization in Europe or the U.S.?
  5. How should market access shape our strategy in Europe or the U.S.?
  6. What capabilities should we build internally versus source externally?
  7. How should we prioritize indications, markets or assets across the Atlantic?
  8. What is the right go-to-market model in Europe or the U.S.?
  9. How do we translate U.S. commercial success into European growth—and vice versa?
  10. How does a development-stage biopharma company become a commercial organization?